India’s Zydus Cadila Buys Etna Of Holland To Expand Vaccine Research
This article was originally published in PharmAsia News
Executive Summary
India's Zydus Cadila says it has acquired Etna Biotech, a subsidiary of Crucell of the Netherlands. The acquisition is the sixth by Cadila in the past five years and is aimed at giving the Indian drug maker entry into vaccine innovation. Details of the purchase were not revealed. Cadila cited Etna's expertise in research and development and its "highly evolved research platform" for developing vaccines. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.